Skip to main content
Erschienen in: Virchows Archiv 4/2016

15.07.2016 | Original Article

HIF-1α expression and high microvessel density are characteristic features in serrated colorectal cancer

verfasst von: Anne Tuomisto, José García-Solano, Päivi Sirniö, Juha Väyrynen, Miguel Pérez-Guillermo, Markus J Mäkinen, Pablo Conesa-Zamora

Erschienen in: Virchows Archiv | Ausgabe 4/2016

Einloggen, um Zugang zu erhalten

Abstract

Serrated colorectal adenocarcinoma (SAC) is a morphologically distinct subtype of colorectal cancer (CRC), in which increased HIF-1α mRNA expression and HIF-1α protein stabilization are typical features. Here we aimed to further elucidate HIF-1α protein expression in serrated and non-serrated colorectal carcinomas (CRCs) and their precursor lesions and its association with vascular endothelial growth factor (VEGF) and microvascular density (MVD). HIF-1α and VEGF expressions were determined immunohistochemically in 134 serrated polyps (SPs), 104 non-serrated adenomas (NSAs), 81 SACs, and 74 matched conventional adenocarcinomas (CCs) and were correlated with morphology, clinicopathological features, and MVD. In premalignant lesions, both HIF-1α and VEGF were expressed in the vast majority of SPs and NSAs. In CRCs, HIF-1α protein was also present in 77.8 % of SACs, while only 20.3 % of CCs were HIF-1α proficient. MVD was significantly higher in SACs, but the serrated morphology was the only significant predictor of MVD in CRC in multivariate analyses. HIF-1α protein is often stabilized in well-vascularized SACs, suggesting hypoxia-independent stabilization of HIF-1α. Moreover, HIF-1α stabilization did not associate with oncogenic activation of BRAF or KRAS or Von Hippel-Lindau (VHL) mutation. Prevalent HIF-1α expression in SAC and its precursors support the importance of HIF-1α-mediated pathways for the serrated route of colorectal carcinogenesis.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
3.
Zurück zum Zitat Tuppurainen K, Makinen JM, Junttila O, et al. (2005) Morphology and microsatellite instability in sporadic serrated and non-serrated colorectal cancer. J Pathol 207:285–294. doi:10.1002/path.1850 CrossRefPubMed Tuppurainen K, Makinen JM, Junttila O, et al. (2005) Morphology and microsatellite instability in sporadic serrated and non-serrated colorectal cancer. J Pathol 207:285–294. doi:10.​1002/​path.​1850 CrossRefPubMed
6.
Zurück zum Zitat O’Brien MJ, Yang S, Mack C, et al. (2006) Comparison of microsatellite instability, CpG island methylation phenotype, BRAF and KRAS status in serrated polyps and traditional adenomas indicates separate pathways to distinct colorectal carcinoma end points. Am J Surg Pathol 30:1491–1501. doi:10.1097/01.pas.0000213313.36306.85 CrossRefPubMed O’Brien MJ, Yang S, Mack C, et al. (2006) Comparison of microsatellite instability, CpG island methylation phenotype, BRAF and KRAS status in serrated polyps and traditional adenomas indicates separate pathways to distinct colorectal carcinoma end points. Am J Surg Pathol 30:1491–1501. doi:10.​1097/​01.​pas.​0000213313.​36306.​85 CrossRefPubMed
8.
Zurück zum Zitat García-Solano J, Conesa-Zamora P, Carbonell P, et al. (2012) Colorectal serrated adenocarcinoma shows a different profile of oncogene mutations, MSI status and DNA repair protein expression compared to conventional and sporadic MSI-H carcinomas. Int J Cancer 131:1790–1799. doi:10.1002/ijc.27454 CrossRefPubMed García-Solano J, Conesa-Zamora P, Carbonell P, et al. (2012) Colorectal serrated adenocarcinoma shows a different profile of oncogene mutations, MSI status and DNA repair protein expression compared to conventional and sporadic MSI-H carcinomas. Int J Cancer 131:1790–1799. doi:10.​1002/​ijc.​27454 CrossRefPubMed
9.
Zurück zum Zitat García-Solano J, Conesa-Zamora P, Trujillo-Santos J, et al. (2011) Tumour budding and other prognostic pathological features at invasive margins in serrated colorectal adenocarcinoma: a comparative study with conventional carcinoma. Histopathology 59:1046–1056. doi:10.1111/j.1365-2559.2011.04043.x CrossRefPubMed García-Solano J, Conesa-Zamora P, Trujillo-Santos J, et al. (2011) Tumour budding and other prognostic pathological features at invasive margins in serrated colorectal adenocarcinoma: a comparative study with conventional carcinoma. Histopathology 59:1046–1056. doi:10.​1111/​j.​1365-2559.​2011.​04043.​x CrossRefPubMed
10.
Zurück zum Zitat García-Solano J, Pérez-Guillermo M, Conesa-Zamora P, et al. (2010) Clinicopathologic study of 85 colorectal serrated adenocarcinomas: further insights into the full recognition of a new subset of colorectal carcinoma. Hum Pathol 41:1359–1368. doi:10.1016/j.humpath.2010.04.002 CrossRefPubMed García-Solano J, Pérez-Guillermo M, Conesa-Zamora P, et al. (2010) Clinicopathologic study of 85 colorectal serrated adenocarcinomas: further insights into the full recognition of a new subset of colorectal carcinoma. Hum Pathol 41:1359–1368. doi:10.​1016/​j.​humpath.​2010.​04.​002 CrossRefPubMed
11.
Zurück zum Zitat Zhong H, De Marzo AM, Laughner E, et al. (1999) Overexpression of hypoxia-inducible factor 1alpha in common human cancers and their metastases. Cancer Res 59:5830–5835PubMed Zhong H, De Marzo AM, Laughner E, et al. (1999) Overexpression of hypoxia-inducible factor 1alpha in common human cancers and their metastases. Cancer Res 59:5830–5835PubMed
15.
Zurück zum Zitat Kelly BD, Hackett SF, Hirota K, et al. (2003) Cell type-specific regulation of angiogenic growth factor gene expression and induction of angiogenesis in nonischemic tissue by a constitutively active form of hypoxia-inducible factor 1. Circ Res 93:1074–1081. doi:10.1161/01.RES.0000102937.50486.1B CrossRefPubMed Kelly BD, Hackett SF, Hirota K, et al. (2003) Cell type-specific regulation of angiogenic growth factor gene expression and induction of angiogenesis in nonischemic tissue by a constitutively active form of hypoxia-inducible factor 1. Circ Res 93:1074–1081. doi:10.​1161/​01.​RES.​0000102937.​50486.​1B CrossRefPubMed
17.
Zurück zum Zitat Zhong H, Chiles K, Feldser D, et al. (2000) Modulation of hypoxia-inducible factor 1alpha expression by the epidermal growth factor/phosphatidylinositol 3-kinase/PTEN/AKT/FRAP pathway in human prostate cancer cells: implications for tumor angiogenesis and therapeutics. Cancer Res 60:1541–1545PubMed Zhong H, Chiles K, Feldser D, et al. (2000) Modulation of hypoxia-inducible factor 1alpha expression by the epidermal growth factor/phosphatidylinositol 3-kinase/PTEN/AKT/FRAP pathway in human prostate cancer cells: implications for tumor angiogenesis and therapeutics. Cancer Res 60:1541–1545PubMed
18.
Zurück zum Zitat Krieg M, Haas R, Brauch H, et al. (2000) Up-regulation of hypoxia-inducible factors HIF-1alpha and HIF-2alpha under normoxic conditions in renal carcinoma cells by von Hippel-Lindau tumor suppressor gene loss of function. Oncogene 19:5435–5443. doi:10.1038/sj.onc.1203938 CrossRefPubMed Krieg M, Haas R, Brauch H, et al. (2000) Up-regulation of hypoxia-inducible factors HIF-1alpha and HIF-2alpha under normoxic conditions in renal carcinoma cells by von Hippel-Lindau tumor suppressor gene loss of function. Oncogene 19:5435–5443. doi:10.​1038/​sj.​onc.​1203938 CrossRefPubMed
21.
22.
Zurück zum Zitat Corn PG, Ricci MS, Scata KA, et al. (2005) Mxi1 is induced by hypoxia in a HIF-1-dependent manner and protects cells from c-Myc-induced apoptosis. Cancer Biol Ther 4:1285–1294CrossRefPubMed Corn PG, Ricci MS, Scata KA, et al. (2005) Mxi1 is induced by hypoxia in a HIF-1-dependent manner and protects cells from c-Myc-induced apoptosis. Cancer Biol Ther 4:1285–1294CrossRefPubMed
23.
Zurück zum Zitat Conesa-Zamora P, García-Solano J, García-García F, et al. (2013) Expression profiling shows differential molecular pathways and provides potential new diagnostic biomarkers for colorectal serrated adenocarcinoma. Int J Cancer 132:297–307. doi:10.1002/ijc.27674 CrossRefPubMed Conesa-Zamora P, García-Solano J, García-García F, et al. (2013) Expression profiling shows differential molecular pathways and provides potential new diagnostic biomarkers for colorectal serrated adenocarcinoma. Int J Cancer 132:297–307. doi:10.​1002/​ijc.​27674 CrossRefPubMed
25.
Zurück zum Zitat Koukourakis MI, Giatromanolaki A, Sivridis E, et al. (2006) Lactate dehydrogenase 5 expression in operable colorectal cancer: strong association with survival and activated vascular endothelial growth factor pathway—a report of the tumour angiogenesis research group. J Clin Oncol 24:4301–4308. doi:10.1200/JCO.2006.05.9501 CrossRefPubMed Koukourakis MI, Giatromanolaki A, Sivridis E, et al. (2006) Lactate dehydrogenase 5 expression in operable colorectal cancer: strong association with survival and activated vascular endothelial growth factor pathway—a report of the tumour angiogenesis research group. J Clin Oncol 24:4301–4308. doi:10.​1200/​JCO.​2006.​05.​9501 CrossRefPubMed
26.
Zurück zum Zitat Righi A, Sarotto I, Casorzo L, et al. (2014) Tumour budding is associated with hypoxia at the advancing front of colorectal cancer. Histopathology. doi:10.1111/his.12602 PubMed Righi A, Sarotto I, Casorzo L, et al. (2014) Tumour budding is associated with hypoxia at the advancing front of colorectal cancer. Histopathology. doi:10.​1111/​his.​12602 PubMed
28.
Zurück zum Zitat Kuwai T, Kitadai Y, Tanaka S, et al. (2004) Mutation of the von Hippel-Lindau (VHL) gene in human colorectal carcinoma: association with cytoplasmic accumulation of hypoxia-inducible factor (HIF)-1alpha. Cancer Sci 95:149–153CrossRefPubMed Kuwai T, Kitadai Y, Tanaka S, et al. (2004) Mutation of the von Hippel-Lindau (VHL) gene in human colorectal carcinoma: association with cytoplasmic accumulation of hypoxia-inducible factor (HIF)-1alpha. Cancer Sci 95:149–153CrossRefPubMed
29.
Zurück zum Zitat Miyakis S, Sourvinos G, Liloglou TL, et al. (2000) The von Hippel-Lindau (VHL) tumor-suppressor gene is not mutated in sporadic human colon adenocarcinomas. Int J Cancer 88:503–505CrossRefPubMed Miyakis S, Sourvinos G, Liloglou TL, et al. (2000) The von Hippel-Lindau (VHL) tumor-suppressor gene is not mutated in sporadic human colon adenocarcinomas. Int J Cancer 88:503–505CrossRefPubMed
30.
Zurück zum Zitat Morimoto T, Mitomi H, Saito T, et al. (2014) Distinct profile of HIF1α, PTCH, EphB2, or DNA repair protein expression and BRAF mutation in colorectal serrated adenoma. J Gastroenterol Hepatol 29:1192–1199. doi:10.1111/jgh.12553 CrossRefPubMed Morimoto T, Mitomi H, Saito T, et al. (2014) Distinct profile of HIF1α, PTCH, EphB2, or DNA repair protein expression and BRAF mutation in colorectal serrated adenoma. J Gastroenterol Hepatol 29:1192–1199. doi:10.​1111/​jgh.​12553 CrossRefPubMed
35.
Metadaten
Titel
HIF-1α expression and high microvessel density are characteristic features in serrated colorectal cancer
verfasst von
Anne Tuomisto
José García-Solano
Päivi Sirniö
Juha Väyrynen
Miguel Pérez-Guillermo
Markus J Mäkinen
Pablo Conesa-Zamora
Publikationsdatum
15.07.2016
Verlag
Springer Berlin Heidelberg
Erschienen in
Virchows Archiv / Ausgabe 4/2016
Print ISSN: 0945-6317
Elektronische ISSN: 1432-2307
DOI
https://doi.org/10.1007/s00428-016-1988-8

Weitere Artikel der Ausgabe 4/2016

Virchows Archiv 4/2016 Zur Ausgabe

Neu im Fachgebiet Pathologie

Molekularpathologische Untersuchungen im Wandel der Zeit

Open Access Biomarker Leitthema

Um auch an kleinen Gewebeproben zuverlässige und reproduzierbare Ergebnisse zu gewährleisten ist eine strenge Qualitätskontrolle in jedem Schritt des Arbeitsablaufs erforderlich. Eine nicht ordnungsgemäße Prüfung oder Behandlung des …

Vergleichende Pathologie in der onkologischen Forschung

Pathologie Leitthema

Die vergleichende experimentelle Pathologie („comparative experimental pathology“) ist ein Fachbereich an der Schnittstelle von Human- und Veterinärmedizin. Sie widmet sich der vergleichenden Erforschung von Gemeinsamkeiten und Unterschieden von …

Gastrointestinale Stromatumoren

Open Access GIST CME-Artikel

Gastrointestinale Stromatumoren (GIST) stellen seit über 20 Jahren ein Paradigma für die zielgerichtete Therapie mit Tyrosinkinaseinhibitoren dar. Eine elementare Voraussetzung für eine mögliche neoadjuvante oder adjuvante Behandlung bei …

Personalisierte Medizin in der Onkologie

Aufgrund des erheblichen technologischen Fortschritts in der molekularen und genetischen Diagnostik sowie zunehmender Erkenntnisse über die molekulare Pathogenese von Krankheiten hat in den letzten zwei Jahrzehnten ein grundlegender …